Compositions of novel opioid compounds and method of use thereof
Details for Australian Patent Application No. 2006236622 (hide)
International Classifications
Event Publications
6 December 2007 PCT application entered the National Phase
PCT publication WO2006/113468 Priority application(s): WO2006/113468
20 December 2007 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 14 Nov 2007
22 September 2011 Assignment before Grant
Mount Cook Biosciences, Inc. The application has been assigned to Versi, Ebrahim
22 September 2011 Application Accepted
Published as AU-B-2006236622
19 January 2012 Standard Patent Sealed
11 October 2012 Assignment Registered
Versi, Ebrahim The patent has been assigned to Versi Group LLC
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006236625-N-alkyl-azacycloalkyl NMDA/NR2B antagonists
2006236621-Diagnostic for lung disorders using class prediction
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser